FDA Enforcement Class I Terminated

Medtronic SynchroMed II, Model 8637, (The SynchroMed¿ II Pump is supplied in 20 ml or 40 ml reservoir size.) Sterilized using ethylene oxide. The pump is part of an infusion system that stores and delivers a prescribed drug to a specific site. The implantable components of the SynchroMed II Infusion System include the pump, catheter, and catheter accessories.

Recall: Z-0497-2013 · Reported December 19, 2012

Enforcement

Recall Number
Z-0497-2013
Event ID
63712
Classification
Class I
Status
Terminated
Product Type
Devices
Firm
Medtronic Neuromodulation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
December 19, 2012
Initiation Date
November 9, 2012
Classification Date
December 13, 2012
Termination Date
December 31, 2017
Address
7000 Central Ave NE, N/A, Minneapolis, MN, 55432-3568, United States

Description

Medtronic SynchroMed II, Model 8637, (The SynchroMed¿ II Pump is supplied in 20 ml or 40 ml reservoir size.) Sterilized using ethylene oxide. The pump is part of an infusion system that stores and delivers a prescribed drug to a specific site. The implantable components of the SynchroMed II Infusion System include the pump, catheter, and catheter accessories.

Reason

Medtronic notified Healthcare Professionals of the impact of unapproved drugs on the performance of the SynchroMed infusion pump system. Use of unapproved drugs with SynchroMed pumps can result in an increased risk of permanent motor stall and cessation of drug infusion. UPDATE 2/1/2016: Medtronic received approval to incorporate enhancements to the SynchroMed II pump which decreases the potential for internal electrical shorting and motor corrosion, and is retrieving any unused pumps.

Code Info

All SynchroMed EL and SynchroMed II pumps

Distribution

Worldwide distribution: USA (nationwide) and countries including: Canada and Mexico.

Quantity

174,700 devices total